Royal Australian Feb 2010 Clinical Not reported Serum 25-(OH)D is one of the College of General guideline for the recommended laboratory tests Practitioners prevention and used for the diagnostic treatment of (RACGP)() assessment for osteoporotic osteoporosis in fractures, but only under postmenopausal particular conditions* women and older men. Kidney Health July 2012 Vitamin D Early chronic kidney disease “Regular” Australia CARI therapy monitoring not patients on vitamin D therapy guidelines (Caring for defined have their 25-(OH)D levels Australasians with in early monitored regularly Renal Impairment)() kidney disease. Pregnant women and children The Royal College of May Use and Routine screening for vitamin D Retesting three Pathologists of 2013 interpretation of months after deficiency is not recommended Australasia (RCPA)() vitamin D commencement in pregnant women, healthy testing; a infants and children of Position supplementation Statement Working Group of the Feb 2013 Vitamin D and Annual testing Population-wide screening for Australian and New health in of people with vitamin D status in infants, Zealand Bone and pregnancy, risk factors for children and adolescents is not Mineral Society and infants, children low vitamin D. supported by the evidence Osteoporosis and adolescents Follow-up 25-(OH)D levels should be Australia() in Australia and testing should be tested in those with one or more New Zealand: a performed in risk factors for low vitamin D€ Position patients on Infants, children and adolescents Statement vitamin D with ongoing risk factors require supplementation ongoing monitoring of vitamin D status with annual testing For neonates Recently arrived migrant with moderate or children at risk of low vitamin D severe should have testing repeated at deficiency, the end of their first winter in follow-up at one Australia. month is Vitamin D testing could be recommended; considered in exclusively in other groups, breastfed infants or mixed fed follow-up at infants with at least one other three months is risk factor usually more Universal screening of pregnant practical; and in women is not supported by the the long term, evidence annual testing is Pregnant women with one or recommended. more risk factors should be tested at their first antenatal visit Very frequent and again at gestation 28 weeks’ testing should be avoided.
Royal Australian College of General Practitioners (RACGP)() Feb 2010 Clinical guideline for the prevention and treatment of osteoporosis in postmenopausal women and older men. Serum 25-(OH)D is one of the recommended laboratory tests used for the diagnostic assessment for osteoporotic fractures, but only under particular conditions* Not reported Kidney Health Australia CARI guidelines (Caring for Australasians with Renal Impairment)() July 2012 Vitamin D therapy in early kidney disease. Early chronic kidney disease patients on vitamin D therapy have their 25-(OH)D levels monitored regularly “Regular” monitoring not defined Pregnant women and children The Royal College of Pathologists of Australasia (RCPA)() May 2013 Use and interpretation of vitamin D testing; a Position Statement Routine screening for vitamin D deficiency is not recommended in pregnant women, healthy infants and children Retesting three months after commencement of supplementation Working Group of the Australian and New Zealand Bone and Mineral Society and Osteoporosis Australia() Feb 2013 Vitamin D and health in pregnancy, infants, children and adolescents in Australia and New Zealand: a Position Statement Population-wide screening for vitamin D status in infants, children and adolescents is not supported by the evidence 25-(OH)D levels should be tested in those with one or more risk factors for low vitamin D€ Infants, children and adolescents with ongoing risk factors require ongoing monitoring of vitamin D status with annual testing Recently arrived migrant children at risk of low vitamin D should have testing repeated at the end of their first winter in Australia. Vitamin D testing could be considered in exclusively breastfed infants or mixed fed infants with at least one other risk factor Universal screening of pregnant women is not supported by the evidence Pregnant women with one or more risk factors should be tested at their first antenatal visit and again at 28 weeks’ gestation Annual testing of people with risk factors for low vitamin D. Follow-up testing should be performed in patients on vitamin D supplementation For neonates with moderate or severe deficiency, follow-up at one month is recommended; in other groups, follow-up at three months is usually more practical; and in the long term, annual testing is recommended. Very frequent testing should be avoided.
Vitamin%20D%20testing%20Review%20Report.docx